Therapy for spondyloarthritis: the role of extra-articular manifestations (eye, skin).

@article{Carron2012TherapyFS,
  title={Therapy for spondyloarthritis: the role of extra-articular manifestations (eye, skin).},
  author={Philippe Carron and Liesbet Van Praet and Peggy Jacques and Dirk Elewaut and Filip van den Bosch},
  journal={Rheumatic diseases clinics of North America},
  year={2012},
  volume={38 3},
  pages={
          583-600
        }
}
Spondyloarthritis can be considered one of the prototypes (besides rheumatoid arthritis) of an inflammatory rheumatic disease. The locomotor system is prominently involved with arthritis, enthesitis, dactylitis, sacroiliitis, and/or axial disease; but besides the rheumatologic component, other body systems are frequently affected. Extra-articular manifestations are all the medical conditions and symptoms that are not directly related to the locomotor system. Besides inflammatory bowel diseases… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 92 references

Lack of efficacy of abatacept in axial spondyloarthropathies refractory to tumor-necrosis-factor inhibition

FK Lekpa, V Farrenq, F Canouı̈-Poitrine
Joint Bone Spine 2012;79:47–50 • 2012

Tocilizumab (TCZ) is not effective for the treatment of ankylosing spondylitis (AS): results of a phase 2, international, multicentre, randomised, double-blind, placebo-controlled trial

J Sieper, B Porter-Brown, L Thompson
Ann Rheum Dis • 2012

Ustekinumab in patients with active psoriatic arthritis : results of the phase 3 multicenter , double - blind , placebo - controlled PSUMMIT I study

IB McInnes, A Kavanaugh, AB Gottlieb
Ann Rheum Dis • 2012

on behalf of the PSUMMIT I Study Group. Ustekinumab in patients with active psoriatic arthritis: results of the phase 3 multicenter, double-blind, placebo-controlled PSUMMIT I study

IB McInnes, A Kavanaugh, AB Gottlieb
Ann Rheum Dis • 2012
View 1 Excerpt